Sameer Ralhan - 30 Aug 2021 Form 4 Insider Report for Chemours Co (CC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Aug 2021, 19:56:49 UTC
Prior SEC filing
30 Aug 2021
Next SEC filing
03 Dec 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Pauletta Brown, Attorney-in-Fact

Key filing fact

Sameer Ralhan filed Form 4 for Chemours Co (CC) on 30 Aug 2021.

Key facts

  • This page summarizes Sameer Ralhan's Form 4 filing for Chemours Co (CC).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 Aug 2021, 19:56.

Change

  • Previous filing in this sequence was filed on 30 Aug 2021.
  • Current net transaction value: -$31,280.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Options Exercise

Transaction value
$34,870
Shares
+1,890
Change %
+0.63%
Price
$18.45
Shares after
300,682
Date
30 Aug 2021
Ownership
Direct
Footnotes
F1, F2
CC transaction

Common Stock

Sale

Transaction value
$66,150
Shares
-1,890
Change %
-0.63%
Price
$35.00
Shares after
298,792
Date
30 Aug 2021
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CC transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-1,890
Change %
-9.8%
Price
$0.000000
Shares after
17,482
Date
30 Aug 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,890
Exercise price
$18.45
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021.

Footnote F2

Includes directly owned shares, restricted stock units, and dividend equivalent units.

Footnote F3

Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .